Pharmacogenomics of Hypertension in CKD: The CKD-PGX Study.
Michael T EadonJudith MaddatuSharon M MoeArjun D SinhaRicardo Melo FerreiraBrent W MillerS Jawad SherJing SuVictoria M PrattArlene B ChapmanTodd C SkaarRanjani N MoorthiPublished in: Kidney360 (2022)
There is a potential role for the addition of pharmacogenomic testing to optimize antihypertensive regimens in patients with CKD.